Stroke was the third leading cause of disability in the year 2015, and it remains the second highest cause of mortality worldwide, claiming over 10% of all deaths (1, 2). Rapid administration of intravenous recombinant tissue-type plasminogen activator (r-tPA) is the first-line treatment for eligible patients within the therapeutic time frame of 4.5 h. Within 6 h of symptom onset, additional endovascular treatment (EVT) with a stent retriever can be performed in patients with large artery occlusion (LAO) (3). Recent prospective trials studied EVT efficacy for clinically-selected patients with acute ischemic stroke (AIS) that had developed a carotid or proximal LAO with a small infarct core and sufficient collateral flow. They demonstrated that an EVT provided substantially better outcomes compared to treating with intravenous r-tPA alone (4-8). In addition, a recent metaanalysis suggested that for LAO, the time window for performing an additional EVT could be extended up to 7.3 h after symptom onset without compromising the beneficial results (9) . The recent DAWN trial results supported the use of a mechanical thrombectomy within a 24-h time window for patients with a persistent significant penumbra, demonstrated with multimodal imaging (10) .
The prevalence and incidence of AIS increases with age. Patients over 85 years old comprise 17% of all patients with stroke (11) . Although the literature on EVT is encouraging, very old patients were often either excluded from larger trials, due to a predetermined upper age limit (6, 7), or they represented only a small proportion of the study population (4, 5, 8) . Some recent studies have indicated that EVT carried a significantly higher risk of mortality and morbidity for octogenarians (i.e. patients aged over 80 years) compared to younger patients, despite a successful recanalization (12) (13) (14) . On the other hand, octogenarians seemed to benefit more from EVT compared to the standard r-tPA treatment alone (15) . Even among the oldest patients (over 90 years old), an excellent prestroke functional status was associated with a reasonable chance of favorable EVT results (16) . Consistent with the earlier studies, a 2016 HERMES meta-analysis, which combined data from five large RCTs, showed that EVT treatment was significantly more beneficial than rtPA alone among patients 80 years or older (17) .
Several studies have shown that advanced age is a remarkable overall risk factor for poor functional EVT outcomes. Nevertheless, no definitive guidelines currently exist that address which older patients should be selected for intra-arterial recanalization therapy or what level of pre-stroke functional status is required to obtain beneficial results. At our university hospital, the decision to perform EVT for AIS is based on similar criteria for older and younger patients. The aim of this retrospective, single-center, registry study was to compare EVT results between octogenarians and patients under age 80 years. We also studied the correlation between the observation of leptomeningeal collateral flow on admission images and clinical outcome after EVT.
Materials and Methods
Study design. This retrospective registry study was approved by the Kuopio University Hospital Research Ethics Board (no. 5772789). All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. Between September 2009 and December 2015, among an estimated 4,000 consecutive patients admitted to our tertiary hospital with intention-to-treat AIS, patients with LAO were selected to undergo an endovascular reperfusion procedure. Prior to EVT, all patients routinely underwent similar examinations, with no distinction between older and younger patients. On admission, a neurologist evaluated the clinical status, based on the National Institute of Health Stroke Scale (NIHSS) (18) and multimodal imaging, including non-contrast computed tomography (NCCT), cervicocranial computed tomographic angiography (CTA), and computed tomographic perfusion imaging (CTP; from 2012). Individual treatment decisions were based on the symptom onset time, the travel distance to the hospital, other underlying diseases, and the prestroke functional status (Table I) (19) .
Patients. Consecutive patients with AIS were selected for EVT when a CTA confirmed vessel occlusion, when the penumbra was considered salvageable, and when the infarct core was not substantially large. The NIHSS status was evaluated at the onset of stroke. Of these consecutive EVT-treated patients (N=261), the following inclusion criteria were used to select patients for the present study: age 18 years or older; a LAO in the middle cerebral artery (MCA; M1 or M2 segment) or in the internal carotid artery (ICA), with or without an intracranial thrombus component, confirmed on the admission imaging; and available follow-up information for 1 year after the AIS onset.
Sixty-two patients that underwent EVT were excluded due to the following: age under 18 years in two; a posterior circulation occlusion in 43; a stroke due to etiology other than LAO in seven (of which three were anterior A2 segment and four M3 segment occlusions); follow-up data not accessible in five; secondary AIS occurring as a complication of neurosurgical treatment in three; and recurrent stroke during the studied timeline in two cases. The remaining 199 patients (76 females; mean age 67.0±12.9 years) were dichotomized by age; the younger group comprised those under 80 years old (N=162) and the older group comprised those 80 years old or more (octogenarians, N=37). The latter group included three patients over 90 years old (91, 92, and 95 years); no upper limit for patient age was set.
Endovascular procedures. EVT interventions were performed in a dedicated biplane neuroangio suite (Siemens Healthcare, Erlangen, Germany) under general anesthesia or conscious sedation. An 80-cm long introducer sheath (Cook 8F/80; Cook Incorporated, Bloomington, Indiana, USA) and a multipurpose shape guiding catheter were introduced into the cervical ICA over a 5 Fr JR4 diagnostic catheter (Cordis, Miami, FL, USA). A thrombectomy aspiration catheter (5 MAX, 5 MAX 60 or 68; Penumbra Inc., Alameda, CA, USA) was advanced to the occlusion over a Neuro Slider 21 (Acandis, Pforzheim, Germany) or a Prowler Select Plus microcatheter (Codman & Shurtleff Inc., Raynham, MA, USA), with the aid of a 0.014-inch microguidewire (Transend EX or Synchro, Stryker, Fremont, CA, USA). The first attempt to remove the thrombus was usually performed with vacuum aspiration, but when that method was not technically feasible or ineffective, a stent retriever was used (Solitaire, Medtronic, Minneapolis, MN, USA; or Trevo, Stryker). In addition, during removal with the stent retriever and/or inner coaxial catheters, manual aspiration through the 8 Fr guiding catheter was invariably performed. In cases where an underlying atherosclerotic occlusion was present in the proximal ICA, a balloon dilation was performed, followed by stent placement with a filter (Carotid Wallstent and FilterWire, Boston Scientific, Marlborough, MA, USA), typically in the last stage of the intervention.
Patient and procedural characteristics. Based on the medical history and prescribed medications, we recorded each patient's age, gender, and any manifestation of medically treated hypertension, diabetes, hypercholesterolemia, known atrial fibrillation (AF), or coronary artery disease (CAD). Postprocedural reperfusion was considered successful when a score of 2b or 3 was achieved on the Thrombolysis in Cerebral Infarction (TICI) scale (20) . The modified Rankin scale (mRS) was used to measure the degree of disability, based on the guidelines from the American Stroke Association (3, 21). One-year mortality was evaluated based on each patient's medical history data. Procedural complications consisted of nine limited vascular dissections and 10 vascular perforations with hemorrhage. Nine other non-specific complications were recorded; these were related to instrumental failure, difficult vascular spasms, or other intracerebral hemorrhages. Postprocedural complications were studied separately; they consisted of 14 reperfusion hemorrhages, one subdural hematoma, two puncturesite hemorrhages, six non-specific hemorrhages from other organs, and 30 other complications, including heart failure, epileptic seizure, pneumonia or other infections, and elevated intracranial pressure due to edema with or without hemicraniectomy.
Collateral score analysis. A single observer (SK), blinded to the retrospective clinical information, evaluated CTA source images with the collateral score (CS) system, according to Souza et al. (22) (CS=0: Absent collaterals in >50% of affected M2 vascular region; CS=1: diminished collaterals in >50% of M2 region; CS=2: in vivo 32: 1223-1230 (2018) diminished collaterals in <50% of M2 region; CS=3: collateral abundance equal to that on the contralateral side; and CS=4: collateral abundance greater than that on the contralateral side). The scores were further dichotomized into categories of malignant (CS=0) versus other (CS>0), and poor (CS<2) versus good (CS≥2) (23 Multiple linear regression analyses were performed only when the data met the following assumptions: linearity, independence, normally distributed, and equal variance of residuals in the outcome variable. The number needed to treat (NNT) values were calculated from the absolute difference between groups in risk of reaching favorable (i.e. ≤2) and unfavourable (i.e. >2) 3-month follow-up mRS scores. Data on age-matched control groups that received only standard care were acquired from a meta-analysis that focused on patients treated with the Solitaire™ Revascularization Device from the ESCAPE, REVASCAT, SWIFT-PRIME, and EXTEND-IA trials (5-8, 24). These four trials included 54 control patients, 80 years or older, who did not undergo EVT.
Results
The baseline characteristics of the dichotomized study population (N=199) are presented in Table I and procedural and outcome characteristics in Table II . The mean ages were 84.0±3.3 years in the older group (≥80 years old, N=37), and 63.2±11.1 years in the younger group (under 80 years old, N=162). There was a higher proportion of females among the octogenarians (78% vs. 29% p<0.01). Among all patients, the mean age differed significantly between genders (females: 72.9±13.9 years vs. males: 63.4±10.8 years p≤0.01). The mean of reconstructed mRS scores prior to the stroke were 0.5±0.7 in the older group and 0.3±0.7 in the younger group (p=0.026). No significant difference between study groups was observed in the proportions of patients with hypertension, diabetes, hypercholesterolemia, or an earlier stroke history, but the older group had significantly higher prevalence of CAD (49% vs. 20%, p<0.01) and AF (57% vs. 21%, p<0.01). The mean preprocedural NIHSS points were 14.1±5.8 in the older group and 12.7±6.1 in the younger group (p=ns). Successful reperfusion (TICI 2b or 3) was achieved in 75.7% of the older group and 74.7% of the younger group (p≥0.05). The mean onset-to-groin-puncture time was 221±89.6 min for the older group (N=30), which was significantly shorter than the mean time for the younger group (349±177 min, N=148, p=0.021). The mean onset-to-reperfusion time did not differ between the older (290±78 min, N=26) and younger (349±177 min, N=114) groups (p≥0.05). Occlusions occurred significantly less often in the ICA (22% vs. 55%, p<0.01) and significantly more often in the M1 (54% vs. 27%, p<0.01) in the older group compared to the younger group. No statistically significant difference was observed between groups in the frequency of M2 occlusions.
The NNT for a favorable clinical outcome was 12 in the older group and 6 in the younger group. The mean 3-month follow-up mRS scores were significantly higher in the older group (4.0±.2.3 vs. 2.5±1.9, p<0.01, Figure 1) . Favorable 3-month follow-up mRS scores (i.e. ≤2) were achieved less often in the older group than in the younger group (27% vs. 52%, p<0.01). Based on a comparison of the mRS points measured prestroke and at 3 months after the AIS, the older group exhibited greater absolute deterioration than the younger group (3.5±2.4 vs. 2.2±1.9, p<0.01). Patient age was significantly correlated with the 3-month mRS score (r=0.26, p<0.01). In the total patient population, males had better 3-month mRS scores than females (males 2.5±1.9 vs. females 3.2±2.2, p=0.036). However, this difference between sexes was not observed when the age groups were analyzed separately. The 3-month mRS scores of males and females were 2.4±1.8 and 2.7±2.1 in the younger group (p≥0.05), and 4.3±2.6 vs. 3.9±2.3 in the older group (p≥0.05), respectively. The deterioration in mRS points did not differ between male (2.4±2.0) and female (2.8±3.0) patients (p≥0.05). When homoscedasticity, linearity, and equal variance assumptions were not met, multiple linear regression analyses on 3-month mRS scores could not be performed.
Mortality was significantly higher in the older group than in the younger group after 3 months (46% vs. 9.9%, p<0.01) and after 1 year (49% vs. 11%, p<0.01). One-year mortality did not significantly vary between male (17%) and female patients (24%, p≥0.05). The incidence of complications during the intra-arterial procedure did not differ between groups, but complications following hospitalization occurred more frequently in the older group than in the younger group (41% vs. 23% p<0.034). A similar difference was observed between groups in the frequency of total complications (combined procedural/in-hospital occurrences: 49% vs. 31%, respectively, p=0.048).
The two evaluators of collateral scores achieved an ICC of 0.71 (p<0.01). In the younger group, the CSs were inversely correlated with admission NIHSS scores (r=−0.354, p<0.01) and 3-month mRS values (r=−0.212, p<0.01). However, in the older group, no significant correlations were observed (p≥0.05; Figures 2 and 3) . In the younger group, patients with malignant CS had significantly higher admission NIHSS scores than patients with other CS (NIHSS scores: 15.3±4.5 vs. 12.2±6.2; p=0.014). Similarly, younger patients with poor CS had significantly higher admission NIHSS and 3-month mRS values compared to patients with good CS (NIHSS: 15.2±5.0 vs. 11.0±6.2, p<0.01; mRS: 2.8±1.8 vs. 2.2±1.8, p=0.037). No other significant differences were found between the CS categories for other variables.
Discussion
The important role of mechanical thrombectomy in the care of AIS was established in the large prospective randomized controlled trials of 2015, which started a new era in stroke treatment (3-8). However, patients over 80 years old played only a minor role in those analyses; consequently, to date, no exact guidelines exist for EVT treatment in very aged individuals. In the present single-center retrospective study, we examined the results of thrombectomy in 199 consecutive patients treated for AIS. The efficacy of EVT between octogenarians and patients under 80 years old was compared.
in vivo 32: 1223-1230 (2018) We observed that a favorable 3-month mRS score (i.e. 0-2) was achieved more often in the younger group than in the older group. In addition, age above 80 years proved to be a remarkable risk factor for a poor functional outcome after EVT. However, despite that risk factor, 10 out of the 37 older patients achieved a favorable result. In addition, the calculated NNT for achieving a favorable 3-month mRS was 12 in patients over 80 years old, and six in younger patients. This latter comparison was performed with a control group that received standard treatment with r-tPA alone. Thus, our results indicated that despite a poor prognosis, octogenarians clearly benefitted from EVT for AIS.
Older patients with AIS could be expected, in general, to exhibit worse overall performance compared to younger patients. In the present study, the decision to treat with EVT was based on criteria that did not distinguish age; thus, the two age groups underwent similar examinations. The main strength of the present study was the ability to compare the individual pre-stroke mRS scores, which reflected clinical status and functional performance, to the 3-month outcome. This comparison allowed an assessment of the absolute change in functional capacity provided by the EVT treatment. The two age groups exhibited similar symptom severity, indicated by the fact that the reconstructed pre-treatment NIHSS scores, which evaluated the difficulty of the stroke, were not significantly different between groups.
The results of the present single-center study paralleled those achieved in some earlier studies that focused on the usefulness of intra-arterial reperfusion therapy in older patients (12, 13, 25, 26) . The studies conducted by Castonguay et al. (14) , Duffis et al. (25) and Zeevi et al. (26) evaluated functional performance and recovery after AIS and demonstrated a worse outcome in older age groups than in younger age groups. At the same time, the recent 2016 HERMES meta-analysis, which combined data from five large random controlled trials, showed that in older individuals, EVT provided significantly more benefit and notably improved the prognosis compared to the standard treatment with r-tPA alone (17) .
The 1-year mortality rates were significantly different between the age groups, to the benefit of the younger patients. This might partly be explained by the natural increase in mortality, due to age. Furthermore, males seemed to achieve a somewhat better recovery than females, although no difference was observed in the 1-year mortality between genders. Nevertheless, the younger group had a significantly higher proportion of males than the older group. The higher proportion of females in the older group reflected the longer average life expectancy of women in Finland.
In the younger group, the CS was inversely correlated with the admission NIHSS scores and 3-month mRS, but no similar trends were observed in the older group. Young patients with malignant or poor collaterals had significantly higher admission NIHSS scores. Poor collaterals predicted a higher 3-month mRS, but again, only in the younger group. The CS did not seem to predict the outcome of EVT as reliably in the older group as it did in the younger group. However, further studies should be conducted to confirm this finding due to the relatively limited number of older patients included in this study.
This study had several limitations that should be considered when interpreting the results. Firstly, the study was conducted at a single hospital, and a total of 62 patients out of 261 that underwent EVT were excluded because they did not meet the study criteria. Another limitation was the relatively small group of octogenarians (37 patients). The onset-to-groin-puncture time was significantly longer in the younger group compared to the older group (221±90 min vs. 307±256 min). This probably reflected the fact that very old patients were seldom transported from other hospitals to our university hospital for thrombectomy. Despite that difference, the onset-to-reperfusion times were not significantly different between groups.
To date, the efficacy of EVT in older individuals has been investigated in a limited number of studies, and no exact international treatment guidelines have been established for treating this population. The incidence of stroke in older patients is predicted to increase substantially in the next few decades (11, 27) . Therefore, knowledge on the effectiveness of treatment, procedural outcomes, and costs could prove valuable in the assessment of healthcare resources in the near future. Continuous EVT availability should be arranged at all university-level hospitals within reasonable distance from large populations. Moreover, high availability of EVT would benefit healthcare professionals by providing important experience with this therapy.
Conclusion
An age of 80 years and above predicted a significant increase in the risk of functional impairment and greater mortality after EVT for an anterior circulation LAO. We calculated that the NNT was 12 to achieve a 3-month mRS of 2 or less, compared to a control group that received the standard in vivo 32: 1223-1230 (2018) treatment alone. This NNT was comparable to the NNT of 14 for younger patients treated with an intravenous r-tPA to achieve an mRS of 1 or less, within a time window of 180-270 min (28) Therefore, the results of this single-center study indicated that despite a worse recovery rate compared to younger patients, a significant proportion of older patients indeed benefitted from EVT for AIS. In conclusion, an EVT should be carefully considered as a viable option for patients aged 80 years or more, when they meet the other indications for a thrombectomy.
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